Abbott Diabetes Care Inc. et al. vs. DexCom, Inc.

Explore the PTAB proceeding IPR2024-00890 filed by Abbott Diabetes Care Inc. et al. on 2024-05-10. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2024-00890

Filing Date

2024-05-10

Accorded Filing Date

2024-05-10

Institution Decision Date

2024-12-16

Last Modified Date

2025-02-13

Proceeding Type

IPR

Termination Date

2025-01-23

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

Abbott Diabetes Care Inc. et al.

Represented By

Weidenfeller, Scottet al

Patent Owner / Respondent

DexCom, Inc.

Represented By

Hunt, Elisabethet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 2600 - Communications

Patent Information

1 Patent Involved

Respondent Application Number 17132664

Respondent Patent Number 11020031

External Links

Espacenet

Google Patents

Respondent Inventor Peter C. Simpson et al

Respondent Tech Center TC 2600 - Communications

Address and Attorney/Agent Information

14 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Dexcom, Inc. (TRANS) - (Empty)

Customer Number 68851

Address 6340 Sequence Drive, c/o IP Legal Dept, San Diego, CA, 92121, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
37688	Steven Nataupsky	949-760-0404
37966	Mark Wieczorek	619-818-4615
44265	Robert O'Connell	858-203-6054
48208	Laura Johnson	858-352-8913
55884	Paul Pearah	858-509-4008
61420	Cynthia Arko	858-922-9940
65082	Justin Leisey	408-239-3004
67407	Shirin Tefagh	858-658-4351
67924	Erikson Squier	888-738-3646
68800	Alan Chang	909-618-8671
72636	John Sadlik	801-933-4061
73591	Joshua Berk	732-236-2758
76674	Iftekhar Mirza	858-529-4759
76821	Charles Choi	718-807-5825

Proceeding Documents

Notice: refund denied NOTICE

2025-02-13 FILING PARTY: BOARD

Download

Petitioner Request for Refund OTHER

2025-02-11 FILING PARTY: PETITIONER

Download

TERMINATION Termination Due to Settlement After Institution of Trial and Granting Joint Request to Treat Settlement Agreement as Business Confidential Information 35 U.S.C.317; 37 C.F.R. 42.74 TERMINATE

2025-01-23 FILING PARTY: BOARD

Download

Joint Request to Treat Settlement Agreement as Business Confidential OTHER

2025-01-14 FILING PARTY: PETITIONER

Download

Joint Motion to Terminate the Proceedings MOTION

2025-01-14 FILING PARTY: PETITIONER

Download

Abbott Diabetes Care Inc. et al. vs. DexCom, Inc.

Proceeding Overview

Parties & Counsel

Petitioner

Abbott Diabetes Care Inc. et al.

Represented By

Patent Owner / Respondent

DexCom, Inc.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Notice: refund denied NOTICE

Petitioner Request for Refund OTHER

TERMINATION Termination Due to Settlement After Institution of Trial and Granting Joint Request to Treat Settlement Agreement as Business Confidential Information 35 U.S.C.317; 37 C.F.R. 42.74 TERMINATE

Joint Request to Treat Settlement Agreement as Business Confidential OTHER

Joint Motion to Terminate the Proceedings MOTION

SCHEDULING ORDER ORDER

Institution Decision: Grant DECISION

Definition of fluid, interstitial - Dorland's Medical Dictionary Exhibit

Stephens (2018) Exhibit

Forlenza 2019 Exhibit

Lodwig Exhibit

Patent Owner's Response to Petitioner's Explanation of Parallel Petitions OTHER

Koschinsky Exhibit

Patent Owner's Preliminary Response POPR

US20060281985A1 Exhibit

US20060020192A1 Exhibit

Definition of catheter and interstitial fluid - AH Medical Dictionary Exhibit

US20060036143A1 Exhibit

Notice: Notice filing date accorded NOTICE

Ex. 1013 - U.S. Patent 5,786,439 (Van Antwerp) Exhibit

Ex. 1023 - Wilson & Zhang, Introduction to the Glucose, Ch. 1 (2010) Exhibit

Ex. 1026 - Nishida et al., Development of a ferrocene-mediated (1995) Exhibit

Ex. 1002 - Declaration of Anthony Edward Cass (IPR2024-00890) Exhibit

Explanation of Parallel Petitions OTHER

Ex. 1030 - Wisniewski et al., Characterization of Implantable (2000) Exhibit

Ex. 1028 - Alcock & Turner, Continuous Analyte Monitoring, IEEE (1994) Exhibit

Ex. 1003 - File History of U.S. Patent 11,020,031 Exhibit

Ex. 1015 - U.S. Patent Publication 2007-0299617A1 (Willis) Exhibit

Ex. 1019 - Dock et al., Multivariate data analysis (2005) Exhibit

Ex. 1018 - Lesperance, Calibration of the Continuous Glucose (2007) Exhibit

Ex. 1011 - U.S. Patent 6,175,572 (Say) Exhibit

Ex. 1016 - U.S. Patent Publication 2005-0069892A1 (Iyengar) Exhibit

Ex. 1020 - Fraser, Biosensors in the Body, Chapter 1 Exhibit

Ex. 1009 - U.S. Design Patent Application 29-101,218 Exhibit

Ex. 1027 - Heller et al. Implanted Electrochemical Glucose (1999) Exhibit

Ex. 1001 - U.S. Patent 11,020,031 Exhibit

Ex. 1005 - U.S. Patent 4,650,547 Exhibit

Ex. 1031 - Scheduling Order (No. 123cv00239, D. Del. Sept. 19, 2023) Exhibit

Ex. 1025 - Henning, Commercially Available, Ch. 5 (2010) Exhibit

Ex. 1021 - Koudelka-Hep, Biosensors in the Body, Chapter 2 Exhibit

Ex. 1004 - U.S. Patent Publication 2005-0143636A1 (Zhang) Exhibit

Ex. 1017 - U.S. Patent 6,560,471 (Heller-2003) Exhibit

Ex. 1008 - U.S. Patent Publication 2005-0004439A1 (Shin) Exhibit

Ex. 1032 - Hall-Ellis Declaration (031 Patent 1) Exhibit

Ex. 1029 - Frost, Implantable Chemical Sensors (2002) Exhibit

Ex. 1007 - U.S. Patent Publication 2003-0076082A1 (Morgan) Exhibit

Petitioner Power of Attorney NOTICE

Ex. 1024 - Godek & Granger, Macrophage in Wound Healing, Ch. 2 (2010) Exhibit

Petition : as filed PETITION

Ex. 1014 - U.S. Patent Publication 2008-0172205A1 (Breton) Exhibit

Ex. 1012 - U.S. Patent Application 2005-0239154A1 (Feldman) Exhibit

Ex. 1006 - U.S. Patent 4,703,756 Exhibit

Ex. 1022 - Schlosser & Ziegler, Biosensors in the Body, Chapter 5 Exhibit

Ex. 1010 - U.S. Patent 6,424,847 (Mastrototaro) Exhibit